Chartwell Investment Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $29.3M | Buy |
181,051
+3,601
| +2% | +$574K | 1.01% | 10 |
|
|
2024
Q2 | $25.9M | Buy |
177,450
+2,603
| +1% | +$387K | 0.91% | 12 |
|
|
2024
Q1 | $27.7M | Buy |
174,847
+20,783
| +13% | +$3.31M | 0.96% | 13 |
|
|
2023
Q4 | $24.1M | Sell |
154,064
-886
| -0.6% | -$136K | 0.85% | 12 |
|
|
2023
Q3 | $24.1M | Sell |
154,950
-3,142
| -2% | -$518K | 0.93% | 10 |
|
|
2023
Q2 | $26.2M | Buy |
158,092
+9,617
| +6% | +$1.55M | 0.95% | 10 |
|
|
2023
Q1 | $23M | Sell |
148,475
-9,735
| -6% | -$1.57M | 0.87% | 11 |
|
|
2022
Q4 | $27.9M | Sell |
158,210
-210
| -0.1% | -$36.3K | 1.1% | 6 |
|
|
2022
Q3 | $25.9M | Buy |
158,420
+10,195
| +7% | +$1.73M | 1.1% | 6 |
|
|
2022
Q2 | $26.3M | Sell |
148,225
-17,108
| -10% | -$3.05M | 1.06% | 6 |
|
|
2022
Q1 | $29.3M | Sell |
165,333
-17,766
| -10% | -$3.02M | 0.98% | 7 |
|
|
2021
Q4 | $31.3M | Sell |
183,099
-3,835
| -2% | -$628K | 0.91% | 7 |
|
|
2021
Q3 | $30.2M | Buy |
186,934
+16,177
| +9% | +$2.76M | 0.94% | 6 |
|
|
2021
Q2 | $28.1M | Buy |
170,757
+786
| +0.5% | +$130K | 0.83% | 10 |
|
|
2021
Q1 | $27.9M | Sell |
169,971
-2,822
| -2% | -$457K | 0.84% | 9 |
|
|
2020
Q4 | $27.2M | Sell |
172,793
-8,557
| -5% | -$1.26M | 0.87% | 8 |
|
|
2020
Q3 | $27M | Buy |
181,350
+3,532
| +2% | +$523K | 0.99% | 6 |
|
|
2020
Q2 | $25M | Buy |
177,818
+5,723
| +3% | +$834K | 0.97% | 6 |
|
|
2020
Q1 | $22.6M | Buy |
172,095
+24,588
| +17% | +$3.49M | 1.06% | 5 |
|
|
2019
Q4 | $21.5M | Buy |
147,507
+20,524
| +16% | +$2.78M | 0.71% | 17 |
|
|
2019
Q3 | $16.4M | Buy |
126,983
+13,789
| +12% | +$1.82M | 0.55% | 38 |
|
|
2019
Q2 | $15.8M | Buy |
113,194
+51,749
| +84% | +$7.16M | 0.51% | 46 |
|
|
2019
Q1 | $8.59M | Buy |
61,445
+6,675
| +12% | +$894K | 0.28% | 142 |
|
|
2018
Q4 | $7.07M | Sell |
54,770
-25,230
| -32% | -$3.52M | 0.25% | 140 |
|
|
2018
Q3 | $11.1M | Buy |
80,000
+12,775
| +19% | +$1.7M | 0.32% | 111 |
|
|
2018
Q2 | $8.16M | Buy |
+67,225
| New | +$8.39M | 0.24% | 153 |
|
|
2015
Q2 | – | Sell |
-69,500
| Closed | -$6.99M | – | 322 |
|
|
2015
Q1 | $6.99M | Sell |
69,500
-55,440
| -44% | -$5.64M | 0.14% | 210 |
|
|
2014
Q4 | $13.1M | Sell |
124,940
-31,605
| -20% | -$3.33M | 0.27% | 158 |
|
|
2014
Q3 | $16.7M | Sell |
156,545
-2,970
| -2% | -$308K | 0.38% | 93 |
|
|
2014
Q2 | $16.7M | Sell |
159,515
-51,669
| -24% | -$5.22M | 0.35% | 114 |
|
|
2014
Q1 | $20.7M | Buy |
211,184
+1,225
| +0.6% | +$114K | 0.42% | 87 |
|
|
2013
Q4 | $19.2M | Buy |
209,959
+13,585
| +7% | +$1.25M | 0.39% | 91 |
|
|
2013
Q3 | $17M | Buy |
196,374
+25,900
| +15% | +$2.32M | 0.38% | 93 |
|
|
2013
Q2 | $14.6M | Buy |
+170,474
| New | +$14.5M | 0.37% | 96 |
|
Other funds holding JNJ
Chartwell Investment Partners's JNJ Position: Q3 2024 in Review
Chartwell Investment Partners increased its Johnson & Johnson (JNJ) stake by 2% in Q3 2024, buying an estimated $574K and bringing the position to 181,051 shares worth $29.3M. The position accounts for 1.01% of the portfolio, ranked #10.
Chartwell Investment Partners first reported a position in JNJ in Q2 2013 and has held it in 34 quarters since. The position peaked at $31.3M in Q4 2021. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.
- Chartwell Investment Partners held 181,051 shares of Johnson & Johnson worth $29.3M as of Q3 2024.
- Chartwell Investment Partners bought 3,601 Johnson & Johnson shares in Q3 2024, an estimated $574K.
- Johnson & Johnson made up 1.01% of Chartwell Investment Partners's portfolio in Q3 2024, its #10 holding.
- Chartwell Investment Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 34 quarters since.
- Chartwell Investment Partners's Johnson & Johnson position peaked at $31.3M in Q4 2021.
- 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.
Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.